ABSTRACT
Background Epicardial connections from surrounding structures to the right pulmonary vein (PV) antrum impede the PV isolation. This study aimed to evaluate the efficacy of an ablation approach targeting epicardial connections for right PV isolations.
Methods We prospectively enrolled 124 atrial fibrillation patients who underwent initial PV isolations. We identified the activation breakthrough site into the right PV antrum (BT-RPV) on the activation map created during high right atrial pacing before the PV isolation. BT-RPV sites were targeted when right PV isolations were not achieved by a wide antral circumferential ablation (WACA).
Results A BT-RPV was observed in 83 cases (67%). BT-RPV sites were predominantly located on the anterior part of the carina (45% of BT-RPV sites). PV isolation was achieved by a WACA in all 41 cases without BT-RPVs. Among the cases with BT-RPVs, the PV isolation was achieved by a WACA in all 48 cases where all BT-RPV sites were covered by the PV isolation line. Conversely, the PV isolation was completed by a WACA in only 5 out of 35 cases (14%) when not all BT-RPV sites were covered. In 30 cases where the WACA did not achieve the PV isolation, 35 sites were targeted for the BT-RPV ablation. The initial BT-RPV ablation led to a PV isolation at 20 sites, while the remaining 15 BT-RPV sites required a repeat BT-RPV ablation. The ablated area of a successful BT-RPV ablation was 0.9 [0.6–1.2] cm2, corresponding to the area activated within 15 [14-16] ms after the BT-RPV emergence. Ablating the area that was activated within 14 ms after the BT-RPV emergence was associated with successful PV isolations (sensitivity 91% and specificity 100%).
Conclusion Ablation targeting BT-RPV sites is effective for a right PV isolation. However, an extensive ablation area is required to eliminate BT-RPVs.
What is Known?
Pulmonary vein isolation using a wide antral circumferential ablation is sometimes complicated by epicardial connections from neighboring structures to the right pulmonary vein antrum.
The intercaval muscular fibers and septopulmonary bundle can act as substrates for epicardial conduction pathways.
What the Study Adds
Epicardial connections to the right pulmonary vein antrum have been identified in 67% of patients with atrial fibrillation.
Targeted ablation at activation breakthrough sites can effectively disrupt epicardial connections to the right pulmonary vein antrum, significantly enhancing the rate of atrial fibrillation-free survival.
For the complete interruption of these epicardial pathways, ablation is necessary in a specific region, indicated by the area activated within a certain time frame following the onset of the epicardial activation in the right pulmonary vein antrum.
Tweet Ablation targeting the breakthrough point of epicardial connections to the right pulmonary vein antrum is effective for pulmonary vein isolation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the Research and Ethics Committee of the Gunma Prefectural Cardiovascular Center.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Non-standard Abbreviations and Acronyms
- AF
- atrial fibrillation
- BT-RPV
- breakthrough of the activation into the right pulmonary vein antrum
- PV
- pulmonary vein
- WACA
- wide antral circumferential ablation
